EUVIMEDEUVIMED entdecken
Open Access

Concurrent Reduced Expression of Contiguous PKD1, TSC2 and NTHL1 Leading to Kidney Diseases and Multiple Diverse Renal Cancers

Satoru Meguro, Tomoyuki Koguchi, Yusuke Hakozaki, Akifumi Onagi, Kanako Matsuoka, Seiji Hoshi, Junya Hata, Yuichi Sato, Hidenori Akaihata, Masao Kataoka, Soichiro Ogawa, Yoshiyuki Kojima

Cancer Genomics - Proteomics · 2023

DOI: 10.21873/cgp.20363 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Genomics - Proteomics, 2023. Verfasst von Satoru Meguro und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Fukushima Medical University School of Medicine, Fukushima, Japan s-meguro@fmu.ac.jp. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Deoxyribonuclease (Pyrimidine Dimer), Kidney Neoplasms, Polycystic Kidney, Autosomal Dominant. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Renal CellDeoxyribonuclease (Pyrimidine Dimer)Kidney NeoplasmsPolycystic Kidney, Autosomal DominantTuberous Sclerosis Complex 2 ProteinTRPP Cation ChannelsFemaleHumansRNA, MessengerTumor Suppressor Proteins

Stichwörter der Autor:innen

NTHL1PKD1TSC2autosomal dominant polycystic kidney diseaserenal cell carcinomatuberous sclerosis

Substanzen

Deoxyribonuclease (Pyrimidine Dimer)RNA, MessengerTuberous Sclerosis Complex 2 ProteinTumor Suppressor ProteinsTRPP Cation ChannelsNTHL1 protein, human

Autor:innen und Institutionen

  • Department of Urology, Fukushima Medical University School of Medicine, Fukushima, Japan s-meguro@fmu.ac.jp.
  • Department of Urology, Fukushima Medical University School of Medicine, Fukushima, Japan.

Zitieren

APA

Meguro, S., Koguchi, T., Hakozaki, Y., Onagi, A., Matsuoka, K., Hoshi, S., Hata, J., Sato, Y., Akaihata, H., Kataoka, M., Ogawa, S., & Kojima, Y. (2023). Concurrent Reduced Expression of Contiguous PKD1, TSC2 and NTHL1 Leading to Kidney Diseases and Multiple Diverse Renal Cancers. Cancer Genomics - Proteomics. https://doi.org/10.21873/cgp.20363

Vancouver

Meguro S, Koguchi T, Hakozaki Y, Onagi A, Matsuoka K, Hoshi S, et al. Concurrent Reduced Expression of Contiguous PKD1, TSC2 and NTHL1 Leading to Kidney Diseases and Multiple Diverse Renal Cancers. Cancer Genomics - Proteomics. 2023. doi:10.21873/cgp.20363

BibTeX
@article{Meguro2023,
  author = {Meguro, Satoru and Koguchi, Tomoyuki and Hakozaki, Yusuke and Onagi, Akifumi and Matsuoka, Kanako and Hoshi, Seiji and Hata, Junya and Sato, Yuichi and Akaihata, Hidenori and Kataoka, Masao and Ogawa, Soichiro and Kojima, Yoshiyuki},
  title = {Concurrent Reduced Expression of Contiguous PKD1, TSC2 and NTHL1 Leading to Kidney Diseases and Multiple Diverse Renal Cancers},
  journal = {Cancer Genomics - Proteomics},
  year = {2023},
  doi = {10.21873/cgp.20363}
}
Kostenlos starten →